Effects of conventional heparin and low-molecular-weight heparin treatment on lipid metabolism during a single hemodialysis session.
T
T
Camsari
C
C
Cavdar
H
H
Oztüre
B
B
Onvural
I
I
Semin
A
A
Celik
S
S
Kavukçu
D000925:Anticoagulants / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008055:Lipids / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D014280:Triglycerides / Q000097:blood
D000925:Anticoagulants; D005230:Fatty Acids, Nonesterified; D006495:Heparin, Low-Molecular-Weight; D008055:Lipids; D008075:Lipoproteins, HDL; D014280:Triglycerides; D006493:Heparin; D002784:Cholesterol